These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19669860)

  • 1. Long-term culture of leukemic bone marrow primary cells in biomimetic osteoblast niche.
    Hou L; Liu T; Tan J; Meng W; Deng L; Yu H; Zou X; Wang Y
    Int J Hematol; 2009 Oct; 90(3):281-291. PubMed ID: 19669860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients.
    Verfaillie CM; Bhatia R; Miller W; Mortari F; Roy V; Burger S; McCullough J; Stieglbauer K; Dewald G; Heimfeld S; Miller JS; McGlave PB
    Blood; 1996 Jun; 87(11):4770-9. PubMed ID: 8639848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional co-culture of mesenchymal stromal cells and differentiated osteoblasts on human bio-derived bone scaffolds supports active multi-lineage hematopoiesis in vitro: Functional implication of the biomimetic HSC niche.
    Huang X; Zhu B; Wang X; Xiao R; Wang C
    Int J Mol Med; 2016 Oct; 38(4):1141-51. PubMed ID: 27571775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance and expansion of hematopoietic stem/progenitor cells in biomimetic osteoblast niche.
    Tan J; Liu T; Hou L; Meng W; Wang Y; Zhi W; Deng L
    Cytotechnology; 2010 Oct; 62(5):439-48. PubMed ID: 20830608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of BCR/ABL-negative stem cells from marrow or blood of patients with chronic myeloid leukemia.
    Guyotat D; Wahbi K; Viallet A; Piselli S; Campos L
    Leukemia; 1999 Jul; 13(7):991-8. PubMed ID: 10400413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genistein.
    Carlo-Stella C; Dotti G; Mangoni L; Regazzi E; Garau D; Bonati A; Almici C; Sammarelli G; Savoldo B; Rizzo MT; Rizzoli V
    Blood; 1996 Oct; 88(8):3091-100. PubMed ID: 8874208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level.
    Udomsakdi C; Eaves CJ; Swolin B; Reid DS; Barnett MJ; Eaves AC
    Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6192-6. PubMed ID: 1631107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human olfactory mucosa multipotent mesenchymal stromal cells promote survival, proliferation, and differentiation of human hematopoietic cells.
    Diaz-Solano D; Wittig O; Ayala-Grosso C; Pieruzzini R; Cardier JE
    Stem Cells Dev; 2012 Nov; 21(17):3187-96. PubMed ID: 22471939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow.
    Leemhuis T; Leibowitz D; Cox G; Silver R; Srour EF; Tricot G; Hoffman R
    Blood; 1993 Feb; 81(3):801-7. PubMed ID: 7679000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microcavity arrays as an in vitro model system of the bone marrow niche for hematopoietic stem cells.
    Wuchter P; Saffrich R; Giselbrecht S; Nies C; Lorig H; Kolb S; Ho AD; Gottwald E
    Cell Tissue Res; 2016 Jun; 364(3):573-584. PubMed ID: 26829941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCR-ABL expression in different subpopulations of functionally characterized Ph+ CD34+ cells from patients with chronic myeloid leukemia.
    Maguer-Satta V; Petzer AL; Eaves AC; Eaves CJ
    Blood; 1996 Sep; 88(5):1796-804. PubMed ID: 8781437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. iPSC-derived mesenchymal stromal cells are less supportive than primary MSCs for co-culture of hematopoietic progenitor cells.
    Vasko T; Frobel J; Lubberich R; Goecke TW; Wagner W
    J Hematol Oncol; 2016 Apr; 9():43. PubMed ID: 27098268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoblasts and bone marrow mesenchymal stromal cells control hematopoietic stem cell migration and proliferation in 3D in vitro model.
    de Barros AP; Takiya CM; Garzoni LR; Leal-Ferreira ML; Dutra HS; Chiarini LB; Meirelles MN; Borojevic R; Rossi MI
    PLoS One; 2010 Feb; 5(2):e9093. PubMed ID: 20161704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: role of malignant stromal macrophages.
    Bhatia R; McGlave PB; Dewald GW; Blazar BR; Verfaillie CM
    Blood; 1995 Jun; 85(12):3636-45. PubMed ID: 7780147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wharton's jelly mesenchymal stem cell-based or umbilical vein endothelial cell-based serum-free coculture with cytokines supports the ex vivo expansion/maintenance of cord blood hematopoietic stem/progenitor cells.
    Li Q; Zhao D; Chen Q; Luo M; Huang J; Yang C; Wang F; Li W; Liu T
    Stem Cell Res Ther; 2019 Dec; 10(1):376. PubMed ID: 31806004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells from patients with chronic myeloid leukemia do not express BCR-ABL and have absence of chimerism after allogeneic bone marrow transplant.
    Carrara RC; Orellana MD; Fontes AM; Palma PV; Kashima S; Mendes MR; Coutinho MA; Voltarelli JC; Covas DT
    Braz J Med Biol Res; 2007 Jan; 40(1):57-67. PubMed ID: 17224997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wharton's Jelly Mesenchymal Stromal Cells Support the Expansion of Cord Blood-derived CD34
    Lo Iacono M; Russo E; Anzalone R; Baiamonte E; Alberti G; Gerbino A; Maggio A; La Rocca G; Acuto S
    Cell Transplant; 2018 Jan; 27(1):117-129. PubMed ID: 29562783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-Dimensional Co-culture of Human Hematopoietic Stem/Progenitor Cells and Mesenchymal Stem/Stromal Cells in a Biomimetic Hematopoietic Niche Microenvironment.
    Costa MHG; Monteiro TS; Cardoso S; Cabral JMS; Ferreira FC; da Silva CL
    Methods Mol Biol; 2019; 2002():101-119. PubMed ID: 30367359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does long-term culture favor normal clonogenic cells from interferon-treated patients with chronic myelogenous leukemia?
    Pasternak G; Schultheis B; Heissig B; Hörner S; Sick C; Hehlmann R
    Leukemia; 1999 Apr; 13 Suppl 1():S55-64. PubMed ID: 10232367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Osteoblasts differentiated from human marrow bone mesenchymal stem cells support hematopoietic stem/progenitor cells from umbilical cord blood].
    Huang XB; Liu T; Meng WT; Zhi W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):552-6. PubMed ID: 16800941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.